JEREMY R STONE

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease OMAHA, NE NPI 1942562913

General Payments — all program years on this page

$3,003.86

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 70
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $418.76 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $418.7614

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $234.368
2021 $53.354
2022 $489.8625
2023 $1,807.5319
2024 $418.7614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087175331 Novartis Pharmaceuticals Corporation $16.78 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087175339 Novartis Pharmaceuticals Corporation $16.89 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087175345 Novartis Pharmaceuticals Corporation $16.40 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087175351 Novartis Pharmaceuticals Corporation $23.38 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087175355 Novartis Pharmaceuticals Corporation $15.79 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087175357 Novartis Pharmaceuticals Corporation $16.22 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111717295 Amgen Inc. $14.52 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128469007 Bard Peripheral Vascular, Inc. $162.62 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139864608 SANOFI-AVENTIS U.S. LLC $26.13 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154171733 HEARTFLOW, INC. $26.13 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154171735 HEARTFLOW, INC. $29.10 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154871931 Kiniksa Pharmaceuticals International, plc $13.87 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154871941 Kiniksa Pharmaceuticals International, plc $25.20 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154872057 Kiniksa Pharmaceuticals International, plc $15.73 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.